← Leaderboards
Ulrik B. Nielsen
Merrimack Pharmaceuticals, Inc.
$960,265
Attributed
$960,265
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $386.5K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$960,265 · 3
By mechanism
R44$749,999 · 1
R43$210,266 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Receptor Expression”
- James C. Paulson · Scripps Research Institute$42,286,990
- Bert W O'Malley · Baylor College Of Medicine$37,971,442
- Barton F Haynes · Duke University$34,728,620
- Herbert Kim Lyerly · Duke University$34,617,942
- Carlos M Ferrario · Wake Forest University$34,549,500
- Fulton T Crews · University Of North Carolina Chapel Hill$33,872,927
Research focus
Receptor ExpressionPolymerase Chain ReactionAmphiregulinAntibodyAntibody FormationAntigensBaseCancer PatientBetacellulinBiological Signal TransductionBloodBreastCancer Cell LineCancer DiagnosisCancer MicroarrayAutoimmune DisorderCancer TypeCell LineCellsCell TypeCharacteristicsClinical Trials, Phase ICloningAntibodies
Grant awards (4)
Antibody Microarrays for Cancer Diagnostics$386,520
R44 · FY2007 · CA · contact PI
Antibody Microarrays for Cancer Diagnostics$363,479
R44 · FY2006 · CA · contact PI
Predicting Molecular Responses to ErbB inhibitors$107,931
R43 · FY2005 · CA
Production of Antibodies Suitable for Microarrays$102,335
R43 · FY2004 · CA